Orient Pharma Co., Ltd. (TPEX:4166)

Orient Pharma Revenue

In the year 2025, Orient Pharma had annual revenue of 1.40B TWD with 14.52% growth. Orient Pharma had revenue of 441.81M in the quarter ending December 31, 2025, with 38.40% growth.

• Revenue: 1.40B
• Revenue Growth: +14.52%
• P/S Ratio: 4.56
• Revenue / Employee: 8.09M
• Employees: 173
• Market Cap: 6.38B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	1.40B	177.56M	14.52%
Dec 31, 2024	1.22B	332.90M	37.41%
Dec 31, 2023	889.91M	378.05M	73.86%
Dec 31, 2022	511.86M	48.52M	10.47%
Dec 31, 2021	463.34M	51.33M	12.46%